• Adedayo Onitilo MD, PhD, MSCR, FACP

  • Service Line Medical Director

    • Weston - Oncology
    • 3400 Ministry Pkwy. WES Weston, WI 54476


MD, Ogun State University, Sagamu, Ogun State, Nigeria
Internship, Rotations in Medicine and Pediatrics, Ogun State University Teaching Hospital, Sagamu, Nigeria
Internship, Rotations in Medicine, Pediatrics, Obstetrics & Gynecology and Surgery, General Hospital St. George's Grenada in affiliation with St. George's University School of Medicine, Grenada, West Indies
Clinical Experience, Medical Officer/ER Physician, The General Hospital, St. George and Princess Alice Hospital, St. Andrews, Grenada, West Indies
Internship, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
Residency, Internal Medicine, Columbia University College of Physicians & Surgeons, Harlem Hospital Center, New York, NY
MSCR, Master of Science in Clinical Science, Medical University of South Carolina, Charleston, SC
Fellowship, Oncology/Hematology, Medical University of South Carolina, Charleston, SC
PhD, University of Queensland, Brisbane, Queensland, Australia

Work Experience

2004 to 2005:
Oncologist / Hematologist, Marshfield Clinic, Inc. - Wausau Center, Wausau, WI
2004 to 2007:
Oncologist / Hematologist, Wausau Hospital, Wausau, WI
2005 to 2012:
Assistant Director of Clinical Research, Marshfield Clinic Research Foundation, Eastern Division
2005 to 2013:
Clinical Assistant Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2009 to 2014:
Co-Investigator, Community Oncology Research Program (CCOP), Marshfield, WI
2014 to 2015:
Co-Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2005 to 2017:
Attending Physician, Ascension Saint Michael's Hospital, Stevens Point, WI
2005 to 2020:
Oncologist / Hematologist, Ascension Saint Clare's Hospital, Weston, WI
2005 to Present:
Oncologist / Hematologist, Marshfield Medical Center - Weston, Weston, WI
2005 to Present:
Oncologist / Hematologist, Marshfield Medical Center - Weston, Weston, WI
2007 to Present:
Associate Editor, Clinical Medicine and Research, Marshfield Clinic, Inc. - Marshfield Center, Marshfield, WI
2007 to Present:
Director, Breast Program, Marshfield Clinic Inc. , Eastern Division, WI
2009 to Present:
Mentor, Physician Mentorship Program, Marshfield Clinic, Inc., Weston, WI
2010 to Present:
Chair, Hematology / Oncology Department, Marshfield Clinic, Inc., Eastern Division
2013 to Present:
Clinical Professor of Medicine, University of Wisconsin Medical School, Madison, WI
2014 to Present:
Oncology Service Line Leader, Marshfield Clinic, Inc. - Marshfield Center, Marshfield, WI
2015 to Present:
Principal Investigator, Wisconsin NCI Community Oncology Research Program (WiNCORP), Marshfield, WI
2017 to Present:
Oncologist / Hematologist, Marshfield Clinic Cancer Center - Stevens Point, Steven's Point, WI
2017 to Present:
Attending Physician, Marshfield Clinic Merrill Center , Merrill, WI

Board Certifications

2002 to 2022:
American Board of Internal Medicine (2002), Recertified 2012
2004 to 2023:
American Board of Internal Medicine - Hematology (2004), Recertified 2019
2004 to 2023:
American Board Internal Medicine - Oncology (2004), Recertified 2019

Honors & Awards

2014 to 2014:
Marshfield Clinic, Gwen D. Sebold Fellowship for Outstanding Research Award
2017 to 2018:
NCI Community Oncology Research Program (NCORP) Gold Certificate of Excellence
2018 to 2019:
NCI Community Oncology Research Program (NCORP) Principal Investigator Top Treatment Trial Accrual Award
2021 to 2021:
Marshfield Clinic, C. Todd Stewart Clinical Excellence Award
2016 to Present:
Marshfield Clinic, Ebenreiter Distinguished Physician/Scientist Endowment


"Patients always come first for me. I treat everyone as relatives and friends. I will give everyone my best, every time, every day!"

Professional Societies

American Academy of Hospice and Palliative Medicine, Member
American College of Physicians, Member
American Medical Association, Member
American Society of Clinical Oncology, Member
American Society of Hematology, Member
Grenadian Medical Association, Member
International Society of Experimental Hematology, Member
Nigerian Medical Association, Member
South Carolina Medical Association, Member
Society of General Internal Medicine, Member


2009 to 2010:
HMORN, Cancer Research Network Scholar
2013 to 2015:
Wisconsin Cancer Council (WCC), President
NCI NCORP Disparity Integration Committee, Member
Lung Committee, SWOG Research Base, Member
2012 to 2018:
Wisconsin Cancer Reporting System (WCRS) Data Quality Task Force, Member
2017 to 2018:
Thoracic Committee, ECOG-ACRIN Research Base, Member
2019 to 2023:
Governing Member, SWOG Cancer Research Network's Board of Governors (BOG) , Member
2020 to 2023:
American Society of Clinic Oncology (ASCO), Member
2006 to Present:
Marshfield Clinic Cancer Research Network (MC, CRN), Co-Investigator
2006 to Present:
Consortium on Breast Cancer Pharmacogenomics (COBRA), Member
2008 to Present:
Personalized Medicine Research Project (PMRP), Co-Investigator
2008 to Present:
Wisconsin Oncology Network (WON), Principal Investigator
2009 to Present:
Community Clinical Oncology Program (CCOP), Co-Investigator
2010 to Present:
American Cancer Society, Wisconsin State Leadership Council, Member
2010 to Present:
Wisconsin Cancer Council, Steering Committee Member
2020 to Present:
National Cancer Institute (NCI) Ad Hoc Working Group , Member

Select Publications

  • Onitilo AA. (1994). Social costs and medical benefits of genetic information on sickle-cell disease. Pugwash Guidebook.
  • Onitilo AA. (1998). Pernicious anemia presenting as fever, diarrhea, jaundice, anemia and hyperpigmentation. Grenada Medical Journal. 2 :1.
  • Onitilo AA, Olatosi AO, Igbal J, Capps LG. (2001 April). Preoperative cardiac risk assessment prior to ambulatory surgery. J Gen Int Med. 16(1):161.
  • Onitilo AA, Lazarchick J, Brunson CY, Frei-Lahr D, Stuart RK. (2003 December). Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc. 35(8):3089-3092.
    PubMed ID: 14697986
  • Kio EA, Onitilo AA, Lazarchick J, Hanna M, Brunson CY, Chaudhary BA. (2004 November). Sickle cell crisis associated with hemophagocytic lymphohistiocytosis. Am J Hematol. 77(3):229-232.
    PubMed ID: 15495257
  • Onitilo AA, Lin YH, Okonofua EC, Afrin LB, Ariail J, Tilley BC. (2004 December). Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians. Transplant Proc. 36(10):3212-3219.
    PubMed ID: 15686731
  • Chaudhary UB, Rashid MH, Onitilo AA, Bissada NK. (2005 June). Secondary hormonal manipulations in the management of advanced prostate cancer. Can J Urol. 12(3):2666-2676.
    PubMed ID: 16011813
  • Onitilo AA, Kio EA, Singh AK, Lazarchick J. (2005 November). Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leuk Lymphoma. 46(11):1667-1670.
    PubMed ID: 16236620
  • Onitilo AA, Shaw GR. (2005 December). Parvovirus B19 infection in an isolated pancreas transplant recipient. Transplant Proc. 37(10):4433-4435.
    PubMed ID: 16387138
  • Onitilo AA, Skorupa A, Lal A, Ronish E, Mercier RJ, Islam R, Lazarchick J. (2006 July). Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 96(1):84-87.
    PubMed ID: 16807656
  • Onitilo AA, Nietert PJ, Egede LE. (2006 September). Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 28(5):396-402.
    PubMed ID: 16950374
  • Onitilo AA. (2006 December). Delayed profound thrombocytopenia associated with eptifibatide. Am J Hematol. 81(12):984.
    PubMed ID: 16804935
  • Onitilo AA, Engel JM, Olatosi B, Fagbemi SO. (2007 July). Community experience with bortezomib in patients with multiple myeloma. Am J Hematol. 82(7):637-639.
    PubMed ID: 17301970
  • Doi SA. R., Woodhouse NJ., Thalib L, Onitilo AA. (2007 June). Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited. Clin Med Res. 5(2):87-90.
    PubMed ID: 17607042
  • Huncharek MS, Muscat J, Onitilo AA, Kupelnick B. (2007 October). Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies. Eur J Cancer Prev. 16(5):422-429.
    PubMed ID: 17923813
  • Onitilo AA. (2007). Study examines breast cancer drug effectiveness. Personalized Medicine. 2(2):1, 4.
  • Onitilo AA, Kio EA, Doi SA. R.. (2007 December). Tumor-related hyponatremia. Clinical Medicine & Research. 5(4):218-26.
    PubMed ID: 18086907
  • Onitilo AA. (2007 September). Testicular microlithiasis: another starry sky appearance. Clinical Medicine & Research. 5(3):163-164.
    PubMed ID: 18056024
  • Onitilo AA, Engel JM, Demos JM, Mukesh BNanjan. (2008 September). Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. Clinical Medicine & Research. 6(2):72 -77.
    PubMed ID: 18801952
  • Ghbeis M, Onitilo AA, Greenlee RT, Vidaillet HJ. (2008). Abstract 3131: Primary Cardiac Malignant Tumors. Incidence, Trends and Survival. CIRCULATION. 118(S):1098-S_1099.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. (2008 May). Breast cancer subtypes based on ER/PR and HER2 expression: A population-based experience. JOURNAL OF CLINICAL ONCOLOGY. May 20 suppl; abstr 22181
  • Engel JM, Onitilo AA, Demos JM, Mukesh BNanjan. (2008 May). Prognostic significance of (18) F-fluorodeoxyglucose positron emission tomography after treatment in patients with limited stage small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. 26:2008(May 20 suppl; abstr 7591)
  • Onitilo AA, Engel JM. (2009 November). Managing Relapse of CML Using Therapeutic Imatinib Plasma Level Clin Adv Hematol Oncol. 7(11):763-7.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. (2009 June). Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res. 7(1-2):4-13.
    PubMed ID: 19251585
  • Doi SA. R., Onitilo AA. (2009 June). Author Reply Clinical Medicine & Research. 7(1-2):2-3.
  • Onitilo AA, McCarty CA, Wilke RA, Glurich IE, Engel JM, Flockhart DA,...Gin Y. (2009 June). Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 115(3):643-50.
    PubMed ID: 19082882
  • Onitilo AA, Engel JM, Lundgren CIhre, Hall P, Thalib L, Doi SA. R.. (2009 April). Simplifying the TNM system for clinical use in differentiated thyroid cancer. JOURNAL OF CLINICAL ONCOLOGY. 27(11):1872-8.
    PubMed ID: 19273697
  • Onitilo AA, Engel JM, Clouse LH, Gerndt KM. (2009 February). Successful Treatment of Mitomycin-induced Thrombotic Thrombocytopenic Purpura with Rituximab. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 20(2):275-6.
    PubMed ID: 19054690
  • Doi SA. R., Engel JM, Onitilo AA. (2010 June). Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma. Clin Nucl Med. 35(6):396-9.
    PubMed ID: 20479583
  • Feigelson HS, Bischoff K, Bowles E, Engel JM, James T, Onitilo AA,...McCahill L. (2010 December). PS2-24: Improving Breast Cancer Surgery Quality Through a Collaborative Surgical Database Clinical Medicine & Research. 8(3-4):180.
  • Onitilo AA, Engel JM, Resnick JM. (2010 March). Prostate carcinoma metastatic to the stomach: report of two cases and review of the literature. Clinical Medicine & Research. 8(1):18-21.
    PubMed ID: 20305145
  • Onitilo AA, Engel JM, Tanimu SB, Nguyen TT. (2010 Jul). Anthracosis and Large Mediastinal Mass in a Patient with Healed Pulmonary Tuberculosis. Clinical Medicine & Research. 8(2):99-103.
  • Feigelson HS, Goddard KA, Rahm A, Pawloski P, McCarty CA, Onitilo AA,...Potosky A. (2010 December). PS1-14: Utilization and Effectiveness of KRAS Testing for Colorectal Cancer Clinical Medicine & Research. 8(3-4):192.
  • Onitilo AA, Engel JM, Sajjad SM. (2011 August). The possible role of hemochromatosis in testicular cancer. MEDICAL HYPOTHESES. 77(2):179-81.
    PubMed ID: 21549511
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M,...Wagner E [including McCarty CA, Onitilo AA.] (2011 November). C-C1-02: Validity of HMO Administrative Data for Breast Cancer Chemotherapy Exposure. Clinical Medicine & Research. 9(3-4):146.
  • Depke JL, Onitilo AA. (2011 March). Coalition building and the Intervention Wheel to address breast cancer screening in Hmong women. Clinical Medicine & Research. 9(1):1-9.
    PubMed ID: 21441527
  • Bowles E, Feigelson HS, Sterrett A, Barney T, Broecker K, Bischoff K,...McCahill L [including Engel JM, Onitilo AA.] (2011 November). PS2-03: Improving Quality Of Breast Cancer Surgery Through Development of a National Breast Cancer Surgical Outcomes Database. Clinical Medicine & Research. 9(3-4):144.
    PubMed ID: 22090527
  • Bowles E, Wellman R, Delate T, Allen L, Feigelson HS, Yood M,...Wagner E [including McCarty CA, Onitilo AA.] (2011 November). C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network Clinical Medicine & Research. 9(3-4):148.
  • Onitilo AA, Engel JM, Berg RL. (2011 November). C-B2-02: Epidemiology of Tamoxifen and Thromboembolism Clinical Medicine & Research. 9(3-4):150.
    PubMed ID: 22090543
  • Klimant E, Glurich IE, Mukesh BNanjan, Onitilo AA. (2011 November). Blood type, hormone receptor status, her2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clinical Medicine & Research. 9(3-4):111-8.
    PubMed ID: 21263059
  • Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking WG, Yale SH, Mazza JJ. (2012 October). Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis. 2012 :142615.
    PubMed ID: 23213505
  • Rocque G, Onitilo AA, Engel JM, Pettke E, Boshoven A, Kim K,...Burkard ME [including Waack B.] (2012 January). Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat. 131(2):713-21.
    PubMed ID: 22065290
  • Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M,...Wagner E [including Onitilo AA.] (2012 April). Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure. Cancer Epidemiol Biomarkers Prev.. 21(4):673-80.
    PubMed ID: 22337532
  • Onitilo AA, Demos JM, Depke JL, Resnick JM, Engel JM. (2012 June). Digital ischemia as a paraneoplastic consequence of squamous cell lung carcinoma. WMJ. 111(3):138-42; quiz 142.
  • Aiello Bowles E, Wellman R, Feigelson HS, Onitilo AA, Freedman A, Delate T,...for the Pharmacovigilance Study Team. (2012 August). Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst.. 104(17):1293-305.
    PubMed ID: 22949432
  • Onitilo AA, Govinda A, Engel JM. (2012 October). Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review. Clin Adv Hematol Oncol. 10(10):689-91.
    PubMed ID: 23187778
  • Feigelson HS, Onitilo AA, James T, Bowles EA, Single R, Barney T,...McCahill L [including Engel JM.] (2012 August). CA2-04: Variation in Mastectomy Rate for Invasive Breast Cancer: Results from the Breast Cancer Surgical Outcomes Study. Clinical Medicine & Research. 10(3):151-2.
    PubMed ID: 22904404
  • Onitilo AA, Engel JM, Feigelson HS, Bowles EA, Single R, James T, McCahill L. (2012 August). PS1-16: Patterns of Surgical Care for Ductal Carcinoma In-situ. Clinical Medicine & Research. 10(3):148.
    PubMed ID: 22904394
  • Goddard KA, Aiello Bowles E, Spencer Feigelson H, Habel LA, Alford S, McCarty CA,...Webster J [including Onitilo AA.] (2012 November). Utilization of HER2 genetic testing in a multi-institutional observational study. AMERICAN JOURNAL OF MANAGED CARE. 18(11):704-12.
    PubMed ID: 23198713
  • Onitilo AA. (2012 March). The debate over lifesaving benefit of screening mammography continues. ARCHIVES OF INTERNAL MEDICINE. 172(5):446-7.
    PubMed ID: 22412117
  • Bowles E, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K,...McCahill L [including Engel JM, Onitilo AA.] (2012 April). Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC CANCER. 12(1):136.
    PubMed ID: 22472011
  • Onitilo AA, Engel JM, Stankowski RV, Liang H, Berg RL, Doi SA. R.. (2012 July). High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. BREAST CANCER RESEARCH AND TREATMENT. 134(1):291-8.
    PubMed ID: 22476854
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2012 July). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 23(7):991-1008.
    PubMed ID: 22527174
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams GH, Doi SA. R.. (2012 June). Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 23(6):967-81.
    PubMed ID: 22552844
  • McCahill L, Single R, Aiello Bowles E, Feigelson HS, James T, Barney T,...Onitilo AA [including Engel JM.] (2012 February). Variability in reexcision following breast conservation surgery. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 307(5):467-75.
    PubMed ID: 22298678
  • Onitilo AA, Doi SA. R.. (2012 October). Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. NUCLEAR MEDICINE COMMUNICATIONS. 33(11):1217-8.
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Johnson JC, Berg RL. (2012 July). Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 130(1):27-31.
    PubMed ID: 22154240
  • Onitilo AA, Doi SA. R., Barendregt JJ. (2013). Meta-analysis II In: Doi, Suhail; Williams, Gail M. (Ed.), Methods of Clinical Epidemiology Textbook Springer.
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. R.. (2013 June). Reliability of reviewer ratings in the manuscript peer review process: an opportunity for improvement. Account Res. 20(4):270-84.
    PubMed ID: 23805832
  • Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak D, Broton M, Doi SA. R.. (2013 November). Mammography Utilization: Patient Characteristics and Breast Cancer Stage at Diagnosis. AJR Am J Roentgenol. 201(5):1057-63.
    PubMed ID: 23952790
  • Liu J, Page D, Nassif H, Peissig PL, McCarty CA, Onitilo AA, Burnside E. (2013 November). Genetic variants improve breast cancer risk prediction on mammograms. AMIA Annu Symp Proc. 2013(eCollection 2013):876-85.
    PubMed ID: 24551380
  • Tanimu SB, Rafiullah, Resnick JM, Onitilo AA. (2013 Oct). Peripancreatic cystic lymphangioma diagnosed by endoscopic ultrasound/fine-needle aspiration: a rare mesenchymal tumour. BMJ Case Rep. :pii: bcr2013200210.
    PubMed ID: 24092605
  • Doi SA. R., Barendregt JJ, Onitilo AA. (2013 August). Methods for the bias adjustment of meta-analyses of published observational studies. J Eval Clin Pract. 19(4):653-7.
    PubMed ID: 22845171
  • Webster J, Kauffman TL, Spencer Feigelson H, Pawloski PA, Onitilo AA, Potosky AL,...Goddard KA [including Cross DS.] (2013 January). KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings. Cancer Epidemiol Biomarkers Prev.. 22(1):91-101.
    PubMed ID: 23155138
  • Onitilo AA, Kar P, Engel JM, Glurich IE. (2013 April). Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 104(2):141-53.
    PubMed ID: 23514990
  • Feigelson HS, James T, single RM, Onitilo AA, Aiello Bowles E, Barney T,...McCahill L. (2013 May). Factors Associated with the Frequency of Initial Total Mastectomy: Results of a Multi-Institutional Study. J Am Coll Surg. 216(5):966-75.
    PubMed ID: 23490543
  • Onitilo AA, Donald M, Stankowski RV, Engel JM, Williams G, Doi SA. R.. (2013 December). Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study. Clinical Medicine & Research. 11(4):210-8.
    PubMed ID: 23669614
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. (2013 December). Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 11(4):201-9.
    PubMed ID: 23656798
  • Glurich IE, Chyou P, Engel JM, Cross DS, Onitilo AA. (2013 February). Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 11(1):16-25.
    PubMed ID: 23411630
  • Onitilo AA, Aryal G, Engel JM. (2013 February). Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment. Clinical Medicine & Research. 11(1):36-41.
    PubMed ID: 22723466
  • Onitilo AA, Engel JM. (2013 February). A New NF1 Variant in a Patient with Atypical Manifestations. American Journal of Medical Genetics Part A. 161(2):389-92.
    PubMed ID: 23322702
  • Onitilo AA, Stankowski RV, Engel JM, Doi SA. R.. (2013 June). Adequate lymph node recovery improves survival in colorectal cancer patients. Journal of Surgical Oncology. 107(8):828-34.
    PubMed ID: 23592545
  • Cross DS, Rahm A, Kauffman TL, Webster J, Le A, Spencer Feigelson H,...Goddard KA [including Onitilo AA.] (2013 December). Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. GENETICS IN MEDICINE. 15(12):933-40.
    PubMed ID: 23639899
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. (2013 June). Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2013 August). Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Onesti J, Single R, Engel JM, James T, Aiello Bowles E,...McCahill L. (2013 December). Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer PLoS One. 8(12):e84535.
  • Braden AM, Stankowski RV, Engel JM, Onitilo AA. (2014 December). Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence. Curr Pharm Des. 20(30):4879-98.
    PubMed ID: 24283956
  • Onitilo AA, Engel JM, Salzman SA, Stankowski RV, Doi SA. R.. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014 November; 21(2):109-21.
    PubMed ID: 24228975
  • Stankowski-Drengler TJ, Stankowski RV, Engel JM, Onitilo AA. (2014 March). The Relationship of Type 2 Diabetes, Oral Diabetes Medications, and Insulin Therapy to Risk for Breast Cancer Curr Nutr Rep. 3(1):1-8.
  • Tanimu SB, Rafiullah, Resnick JM, Onitilo AA. (2014 Apr). Oesophageal papillomatosis, not amenable to endoscopic therapies, treated with oesophagectomy. BMJ Case Reports. 2014 :pii: bcr2013200195.
    PubMed ID: 24789149
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Williams GH, Doi SA. R.. (2014 May). A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record. BMC Medical Informatics & Decision Making. 14(1):38.
    PubMed ID: 24886371
  • Rafiullah, Tanimu SB, Onitilo AA. (2014 Jul). Gangliocytic paraganglioma, a rare ampullary tumour treated with open transduodenal resection and sphincteroplasty. BMJ Case Rep. 2014 :pii: bcr2013202941.
    PubMed ID: 25100803
  • Onitilo AA, Liang H, Stankowski RV, Engel JM, Broton M, Doi SA. R., Miskowiak D. (2014 July). Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis Rural Remote Health. 14(3):2738.
    PubMed ID: 25018129
  • Onitilo AA, Engel JM, Stankowski RV. (2014 August). Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. Ther Adv Drug Saf. 5(4):154-66.
    PubMed ID: 25083270
  • Dart RA, Onitilo AA, Salzman SA, Reed KD, Shukla SK. (2014 September). Ten years of Clinical Medicine & Research. Clin Med Res. 12(1-2):1.
  • Onitilo AA. (2014 September). Is it time for the cochrane collaboration to reconsider its meta-analysis methodology? Clin Med Res.. 12(1-2):2-3.
  • Liu J, Peissig PL, McCarty CA, Onitilo AA, Trentham-Dietz A, Burnside E. (2014 April). New genetic variants improve personalized breast cancer diagnosis. AMIA Jt Summits Transl Sci Proc.. eCollection 2014 :83-9.
    PubMed ID: 25717406
  • Sanfelippo MJ, Engel JM, Onitilo AA. (2014 July). Antithrombin levels are unaffected by warfarin use. Arch Pathol Lab Med.. 138(7):967-8.
    PubMed ID: 24979180
  • Stankowski RV, Engel JM, Stankowski-Drengler TJ, Liang H, Onitilo AA. (2014 September). PS2-42: All-cause Mortality is Decreased in Women Undergoing Annual Mammography Screening Before Breast Cancer Diagnosis Clinical Medicine & Research. 12(1-2):ps2-42.
  • Mankarios D, Baade P, Youl P, Mortimer R, Onitilo AA, Russell A, Doi SA. R.. (2014 June). Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. ENDOCRINE. 46(2):300-308.
    PubMed ID: 24174176
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):76-83.
    PubMed ID: 23571511
  • Allen L, Yood M, Wagner E, Aiello Bowles E, Pardee R, Wellman R,...Pharmacovigilance Research Group [including Onitilo AA.] (2014 May). Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer. MEDICAL CARE. 52(5):e30-8.
    PubMed ID: 22643199
  • Feigelson HS, zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA,...CERGEN STeam [including Cross DS.] (2014 May). Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample PLoS One. 9(5):e94977.
    PubMed ID: 24788807
  • Wu Y, Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Burnside ES. (2014 November 14). Comparing the value of mammographic features and genetic variants in breast cancer risk prediction. AMIA Annu Symp Proc. 2014 :1228-37.
    PubMed ID: 25954434
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. (2014). A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 21(2):109-21.
    PubMed ID: 24228975
  • Engel JM, Stankowski-Drengler TJ, Stankowski RV, Liang H, Doi SA. R., Onitilo AA. (2015 April). All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol.. 204(4):898-902.
    PubMed ID: 25794084
  • Depke JL, Boreen A, Onitilo AA. (2015 December). Navigating the Needs of Rural Women with Breast Cancer: A Breast Care Program. Clin Med Res. 13(3-4):149-55.
    PubMed ID: 26056376
  • Onitilo AA, Engel JM, Stankowski RV, Doi SA. R.. (2015 June). Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research. 13(2):65-73.
    PubMed ID: 25487237
  • Shanle EK, Onitilo AA, Huang W, Kim K, Zang C, Engel JM,...Wisinski KB. (2015 July 15). Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer. Am J Transl Res. 7(7):1246-59.
    PubMed ID: 26328009
  • Liu J, Wu Y, Ong I, Page D, Peissig P, McCarty C,...Burnside E [including Onitilo AA.] (2015 March 25). Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis. AMIA Jt Summits Transl Sci Proc.. 2015 :107-11.
    PubMed ID: 26306250
  • Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O,...Burnside ES [including Peissig P, Onitilo AA.] (2015 August 17). Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. Journal of Medical Imaging. 2(4):041005.
  • Doi SA, Salzman-Scott SA, Onitilo AA. (2016 January 20). Validation of the CoRE Questionnaire for Medical Journal Peer Review. Account Res. 23(1):47-52.
    PubMed ID: 26192007
  • Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD,...Yuan M [including Peissig PL, Kitchner T.] (2016 January 26). Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy. Acad Radiol. 23(1):62-9.
    PubMed ID: 26514439
  • Asare M, Peppone LJ, Roscoe JA, Kleckner IR, Mustian KM, Heckler CE,...Kamen C [including Onitilo A.] (2016 April 21). Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. J Cancer Educ.
    PubMed ID: 27097806
  • Doi SA, Furuya-Kanamori L, Engel JM, Jamal MH, Stankowski RV, Barkun J, Onitilo AA. (2016 May 26). The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study. Cancer Causes Control.
    PubMed ID: 27228990
  • Wu Y, Abbey CK, Liu J, Ong I, Peissig P, Onitilo AA,...Burnside ES. (2016 February 27). Discriminatory power of common genetic variants in personalized breast cancer diagnosis. Proc SPIE Int Soc Opt Eng. 9787
    PubMed ID: 27279675
  • Garg MK, Zhao F, Lee J, Sparano J, Palefsky J, Henry D,...Kachnic LA [including Onitilo A.] (2016 October 1). Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). Int J Radiat Oncol Biol Phys. 96(2S):S106-S107.
    PubMed ID: 27675537
  • Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP,...Benson AB [including Onitilo AA.] Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol. 2017 March; 35(7):718-726.
    PubMed ID: 28068178